dispergerbara tabletter för dosdispenser clinical trials

A multi-center, open label, longitudinal, observational, 12-week study of Flexilev treatment with the dosing device OraFID and accompanying digital app in Parkinson patients.

This study looks at how people with Parkinson's disease use a device called OraFID and a special app to take their Flexilev medicine. It aims to understand how well they use it and how they feel about it over 12 weeks.